

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists...
Q3 2026
Aug 13, 2026
Q2 2026
May 20, 2026
Q1 2026
Feb 13, 2026
FY 2025
Dec 23, 2025
Q4 2025
Dec 23, 2025